Entera Bio (ENTX) EBIT (2019 - 2026)
Entera Bio (ENTX) posted quarterly EBIT of -$3.5 million for Q1 2026, down 38.08% year-on-year from -$5.7 million in Q1 2025, and down 16.84% on a QoQ basis from -$3.0 million in Q4 2025.
Entera Bio (ENTX) EBIT (2019 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported EBIT for 8 consecutive years, with -$3.5 million the latest figure, recorded in Q1 2026.
- Quarterly EBIT fell 38.08% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.6 million (down 24.18% YoY) and the FY2025 annual result came in at -$11.5 million, down 20.28% from the prior year.
- EBIT slipped to -$3.5 million in Q1 2026 per ENTX's latest filing, from -$3.0 million in the prior quarter.
- Over the last five years, EBIT for ENTX reached as high as -$2.0 million in Q4 2023 and fell as low as -$3.8 million in Q1 2022.
- A 5-year average of -$2.7 million and a median of -$2.7 million in 2025 frame the typical range for EBIT.
- Annual changes were most pronounced in 2022 — EBIT slumped 63.96% — and 2023, when it soared 42.32%.
- Year by year, EBIT stood at -$3.1 million in 2022, then surged by 36.02% to -$2.0 million in 2023, then dropped by 19.05% to -$2.3 million in 2024, then fell by 29.61% to -$3.0 million in 2025, then slipped by 16.84% to -$3.5 million in 2026.
- According to Business Quant data, EBIT over the past three periods registered -$3.5 million, -$3.0 million, and -$3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Entera Bio | 189.35 Mn | 185.22 Mn | - | -3.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.54 Mn |
| Dec 31, 2025 | -3.03 Mn |
| Sep 30, 2025 | -3.30 Mn |
| Jun 30, 2025 | -2.70 Mn |
| Mar 31, 2025 | -2.56 Mn |
| Dec 31, 2024 | -2.34 Mn |
| Sep 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | -1.96 Mn |
| Sep 30, 2023 | -2.39 Mn |
| Jun 30, 2023 | -2.33 Mn |
| Mar 31, 2023 | -2.21 Mn |
| Dec 31, 2022 | -3.07 Mn |
| Sep 30, 2022 | -2.87 Mn |
| Jun 30, 2022 | -3.25 Mn |
| Mar 31, 2022 | -3.84 Mn |
| Dec 31, 2021 | -4.09 Mn |
| Sep 30, 2021 | -3.22 Mn |
| Jun 30, 2021 | -2.57 Mn |